{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:15:08Z","timestamp":1761491708421,"version":"3.30.2"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T00:00:00Z","timestamp":1724112000000},"content-version":"vor","delay-in-days":232,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Therapeutic Research"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.curtheres.2024.100759","type":"journal-article","created":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T02:26:20Z","timestamp":1725071180000},"page":"100759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["In Vitro Inhibitory Effect of Nigella sativa L. Extracts on SARS-COV-2 Spike Protein-ACE2 Interaction"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-4182","authenticated-orcid":false,"given":"Najma","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asha Caroline","family":"Cyril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anagha","family":"Parambath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cijo George","family":"Vazhappilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reem Kais","family":"Jan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haneen","family":"Aburamadan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Akbarpoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.\u202fM.","family":"Shariar Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fazilatun","family":"Nessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosra","family":"Lozon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noushad","family":"Karuvantevida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-8234","authenticated-orcid":false,"given":"Rajan","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.curtheres.2024.100759_bib0001","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00431-021-04306-6","article-title":"Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children","volume":"181","author":"Tagarro","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0002","doi-asserted-by":"crossref","first-page":"14214","DOI":"10.1038\/s41598-020-71188-3","article-title":"Dynamics of the ACE2\u2013SARS-CoV-2\/SARS-CoV spike protein interface reveal unique mechanisms","volume":"10","author":"Ali","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100759_bib0003","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nature Microbiology"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100759_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/efd2.77","article-title":"Dietary phytochemicals against COVID-19: a focus on thymoquinone","volume":"4","author":"Li","year":"2023","journal-title":"EFood"},{"key":"10.1016\/j.curtheres.2024.100759_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/2560645","article-title":"Traditional herbal medicine candidates as complementary treatments for COVID-19: a review of their mechanisms, pros and cons","volume":"2020","author":"Nugraha","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"issue":"12","key":"10.1016\/j.curtheres.2024.100759_bib0006","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1080\/07391102.2020.1775129","article-title":"Molecular docking, simulation and MM-PBSA studies of Nigella sativa compounds: a computational quest to identify potential natural antiviral for COVID-19 treatment","volume":"39","author":"Ahmad","year":"2021","journal-title":"J Biomol Struct Dynam"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0007","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s42269-021-00517-x","article-title":"In silico identification of compounds from Nigella sativa seed oil as potential inhibitors of SARS-CoV-2 targets","volume":"45","author":"Duru","year":"2021","journal-title":"Bullet Natl Res Centre"},{"issue":"4","key":"10.1016\/j.curtheres.2024.100759_bib0008","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2174\/0929867328666210420103021","article-title":"SARS-CoV-2 entry inhibitors targeting virus-ACE2 or virus-TMPRSS2 interactions","volume":"29","author":"Lin","year":"2022","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.curtheres.2024.100759_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106856","article-title":"In silico Nigellidine (N. sativa) bind to viral spike\/active-sites of ACE1\/2, AT1\/2 to prevent COVID-19 induced vaso-tumult\/vascular-damage\/comorbidity","volume":"138","author":"Maiti","year":"2021","journal-title":"Vasc Pharmacol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s40121-021-00400-2","article-title":"Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells","volume":"10","author":"Xu","year":"2021","journal-title":"Infect Dis Ther"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0011","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1186\/s13063-021-05510-3","article-title":"Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial","volume":"22","author":"Ashraf","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.curtheres.2024.100759_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2021.102769","article-title":"Nigella sativa for the treatment of COVID-19: an open-label randomized controlled clinical trial","volume":"61","author":"Koshak","year":"2021","journal-title":"Complement Ther Med"},{"issue":"9","key":"10.1016\/j.curtheres.2024.100759_bib0013","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.3390\/molecules27092750","article-title":"Nigella sativa L. and COVID-19: a glance at the anti-COVID-19 chemical constituents, clinical trials, inventions, and patent literature","volume":"27","author":"Imran","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.curtheres.2024.100759_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2023\/8820543","article-title":"Phytochemicals analysis, in vitro antibacterial activities of extracts, and molecular docking studies of the isolated compounds from Melhania zavattarii Cufod Leaves","volume":"2023","author":"Gonfa","year":"2023","journal-title":"J Trop Med"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.curtheres.2024.100759_bib0016","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/13880209.2021.1931353","article-title":"Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19","volume":"59","author":"Khazdair","year":"2021","journal-title":"Pharmaceut Biol"},{"issue":"2","key":"10.1016\/j.curtheres.2024.100759_bib0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2478\/amb-2021-0022","article-title":"Rose extracts and in-vitro inhibition of SARS-CoV-2 spike: The ACE-2 interaction","volume":"48","author":"Arokiaraj","year":"2021","journal-title":"Acta Medica Bulgarica"},{"key":"10.1016\/j.curtheres.2024.100759_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.638187","article-title":"Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): a promising source of novel antiviral drugs","volume":"9","author":"Tito","year":"2021","journal-title":"Front Chem"}],"container-title":["Current Therapeutic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0011393X24000298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,14]],"date-time":"2024-12-14T09:08:54Z","timestamp":1734167334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0011393X24000298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":18,"alternative-id":["S0011393X24000298"],"URL":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100759","relation":{},"ISSN":["0011-393X"],"issn-type":[{"type":"print","value":"0011-393X"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In Vitro Inhibitory Effect of Nigella sativa L. Extracts on SARS-COV-2 Spike Protein-ACE2 Interaction","name":"articletitle","label":"Article Title"},{"value":"Current Therapeutic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.curtheres.2024.100759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100759"}}